Homozygous SLC25A13 mutation in a Taiwanese patient with adult-onset citrullinemia complicated with steatosis and hepatocellular carcinoma

Journal of the Formosan Medical Association

Volumn 105, Issue 10, 2006, Pages 852-856

  Tsai, Ching Wei ^a   Yang, Chih Chao ^a   Chen, Huey Ling ^a   Hwu, Wuh Liang ^a   Wu, Mu Zon ^a   Liu, Kao Lang ^a   Wu, Ming Shiang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adult onset citrullinemia; Hepatocellolar carcinoma; SLC25A13 gene; Steatosis

Indexed keywords

GENE PRODUCT; GENOMIC DNA; PROTEIN SLC25A13; UNCLASSIFIED DRUG;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER GRADING; CASE REPORT; CHROMOSOME 7Q; CITRULLINEMIA; CLINICAL FEATURE; COMA; COMPUTER ASSISTED TOMOGRAPHY; DNA EXTRACTION; ECHOGRAPHY; ELECTROLYTE BALANCE; EXON; GENE LOCATION; GENE MUTATION; HEMODIALYSIS; HEPATITIS; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; HYPERAMMONEMIA; LIVER CELL CARCINOMA; LIVER FUNCTION; MALE; ONSET AGE; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; STEATOSIS; SURGICAL TECHNIQUE; TREATMENT RESPONSE;

EID: 33750846867     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60274-6     Document Type: Article

References (16)

1. Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet 2002;47:333-41.
2. Kobayashi K, Sinasac DS, Iijima M, et al. The gene mutated in adult-onset type II citrullinemia encodes a putative mitachondrial carrier protein. Nat Genet 1999;22: 159-63.
3. Nkamura M, Okamoto Y, Morita T, et al. Promoting effect of citrullinemia in hepatocarcinogenesis: possible mechanisim in hypercitrullinemia. Hepatology 1990;11:819-23.
4. Hwu WL, Kobayashi K, Hu YH, et al. A Chinese adult onset type II citrullinaemia patient with 851del4/1638ins23 mutations in the SLC25A13 gene. J Med Genet 2001; 38:23.
5. Chen YF, Huang YC, Liu HM, et al. MRI in a case of adult-onset citrullinemia. Neuroradiology 2001;43:845-7.
6. Mathias RS, Kostiner D, Packman S. Hyperammonemia in urea cycle disorders: role of the nephrologist. Am J Kidney Dis 2001;37:1069-80.
7. Caturelli E, Ghittoni G, Niro GA, et al. Multiple intrahepatic vascular shunts causing hyperammoniaemic encephalopathy in a patient without liver cirrhosis. Dig Liver Dis 2006; 38:347-51.
8. Kobayashi K, Lu YB, Li MX, et al. Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations. Mol Genet Metab 2003,80:356-9.
9. Ikeda S, Yazaki M, Takei Y, et al. Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation. J Neural Neurosurg Psychiatry 2001; 71:663-70.
10. Ikeda S, Kawa S, Takei Y, et al. Chronic pancreatitis associated with adult-onset type II citrullinemia: clinical and pathologic findings. Ann Intern Med 2004;141:109-10.
11. Saheki T, Kobayashi K, Iijima M, et al. Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle. Mol Genet Metab 2004;8:20-6.
12. Hagiwara N, Sekijima Y, Takei Y, et al. Hepatocellular carcinoma in a case of adult-onset type II citrullinemia. Intern Med 2003;42:978-82.
13. Ito T, Shiraki K, Sekoguchi K, et al. Hepatocellular carcinoma associated with adult-type citrullinemia. Dig Dis Sci 2000;45:2203-6.
14. Dillon BJ, Prieto VG, Curley SA, et al. Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation. Cancer 2004;100:826-33.
15. Yoshioka Y, Hashimoto E, Yatsuji S, et al. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH. J Gastroenterol 2004;39:1215-18.
16. Mori S, Yamasaki T, Sakaida I, et al. Hepatocellular carcinoma with nonalcoholic steatohepatitis. J Gastroenterol 2004;39:391-6.